Structured management of uncomplicated diabetes in Background: primary care constitutes good quality diabetes care. The cycle of care is a national initiative that financially remunerates general practitioners to provide structured diabetes care for people with type 2 diabetes. However, eligibility for the cycle of care is limited to those with means-tested public health insurance. We investigate the national coverage of the cycle of care and describe the socio-demographic and clinical profile of those eligible and non-eligible for the initiative.
Introduction
With rising prevalence and burgeoning healthcare costs, diabetes embodies many of the challenges facing health systems worldwide 1, 2 . The prevalence of doctor-diagnosed diabetes in Ireland has increased from 2.2% of the adult population in 1998 to 5.2% in 2015 3 . Among adults aged 50 years and older, the prevalence of type 2 diabetes is 8.5%
4 . Healthcare costs attributable to diabetes in those aged over 50 years are estimated at €89 million per annum with hospital admissions accounting for almost 70% of costs 5 . Out-patient department visits attributable to diabetes cost an estimated €18.5 million per annum.
International consensus exists that structured management of uncomplicated diabetes in primary care with suitable organisational support, constitutes good quality diabetes care. There is growing evidence that primary care led structured diabetes management is associated with improved outcomes for patients 6, 7 . Structured approaches to diabetes care demonstrate improvements in glycaemic control and cardiovascular risk factors 8, 9 . Integrated diabetes care has been shown to reduce preventable hospitalisations for diabetes-related complications 10 . Recent guidance on integrated care for diabetes in Ireland recommends that patients with uncomplicated type 2 diabetes are managed in primary care and patients with complicated type 2 diabetes are managed between primary and secondary care 11 . The management of type 1 diabetes remains in secondary care. Patients with uncomplicated type 2 diabetes are defined as patients not on insulin, treated by diet or glucose lowering agents only, controlled HbA1c and no diabetes-related complications 11 .
In 2015, the diabetes "cycle of care" was introduced. This is the first national initiative to financially remunerate General Practitioners (GPs) for providing structured care for people with type 2 diabetes. GPs are remunerated for providing two structured diabetes review visits per year. The initiative establishes formal requirements for registering, recording and reporting processes of care. However, GPs are only remunerated for patients covered by means-tested public health insurance schemes. We aim to investigate the coverage of the cycle of care and to describe the socio-demographic and clinical profile of the those eligible and non-eligible for the initiative.
Methods

Data source
A cross-sectional analysis of Wave 1 (2009-2011) of The Irish LongituDinal study on Ageing (TILDA) 12 was conducted. TILDA is a population-based prospective cohort study of communitydwelling adults aged 50 years and over
13
. The sampling frame is the Irish Geodirectory, a comprehensive and up-to-date list of all residential addresses in Ireland 14 . A multistage probability sampling design was used. A total of 8,175 participants from 6,282 households completed a computer-assisted personal interview (CAPI) (response rate: 62%).
Variable definition
Individuals were classified as having diabetes if they self-reported a previous doctor diagnosis. Type 1 diabetes was defined as those who were aged less than 50 years at diabetes diagnosis and reported injecting insulin, but not taking oral hypoglycaemic agents. All others were classified as having type 2 diabetes. Participants who reported a doctor diagnosis of diabetes during the CAPI were asked the question 'Has a doctor ever told you that you have any of the following conditions related to your diabetes?'. The conditions listed were: leg ulcer (peripheral vascular disease), protein in urine (proxy for elevated urine albumin creatinine ratio), lack of feeling and tingling pain in legs and feet due to nerve damage (diabetic neuropathy), damage to the back of your eye (diabetic retinopathy). These were defined as microvascular complications. Participants were considered as having a macrovascular complication if they self-reported a doctor-diagnosis of any of the following: heart attack (myocardial infarction), heart failure (congestive cardiac failure), stroke (cerebrovascular accident) or mini stroke (transient ischaemic attack). Participants who self-reported a doctor diagnosis of diabetes were also asked whether they inject insulin or take any tablets, pills or medications for their diabetes. We categorised diabetes management as injecting insulin, taking tablets only and no medication. During the CAPI, participants were also asked about their health cover where they could indicate if they have a medical card or GP visit card, private insurance or neither. As Ireland has a government-funded public health system, all individuals are entitled to hospital services free of charge, though with a co-payment at point of access. Primary care services are paid for out-of-pocket. A medical card entitles the holder to health cover under the General Medical Scheme. This is a means-tested scheme which entitles an individual to primary care services and hospital services free at the point of access. Prescription items are also provided free of charge under this scheme, albeit with a co-payment. A GP-visit card entitles the holder to free access to primary care services and is also meanstested. The means test criteria differ for those under and over 70 years of age. Participants who reported either having a medical card or a GP-visit card were classed as eligible for the cycle of care. Other variables of interest included age in years (50-64, 65-74, 75+), gender, self-reported health (excellent/very good, good, fair/poor), and education (none/primary, secondary, third level).
Statistical analysis
Pearson's chi-square test was used for the comparison of categorical variables across eligibility status. The proportion of people eligible for the cycle of care was applied to the most recent census population figures (2016) to estimate the absolute numbers of people eligible and not eligible for the initiative 15 . Survey weights were applied to the analysis to reflect the complex sampling design and to adjust for participation bias 14 . A complete case analysis was conducted. Analysis was carried out in Stata v. 13 for windows (StataCorp, College Station, TX, USA) using the survey function (svy).
Results
Of the 8,107 participants with complete data, 609 people had type 2 diabetes (7.9% [95% CI: 7.3%, 8.5%]). 
Discussion
This study describes the proportion, socio-demographic and clinical profile of people with type 2 diabetes according to their eligibility status for the cycle of care initiative. Almost one-third of people over the age of 50 years with type 2 diabetes are not eligible for the initiative. They are more likely to be male, to be younger and to have higher levels of educational attainment than those covered by the scheme.
The aim of the cycle of care is to provide financial remuneration to GPs for providing structured review visits for people with type 2 diabetes in primary care. National guidelines for integrated care identify people with uncomplicated type 2 diabetes as most suitable for management in primary care 11 . Our findings indicate that most of those currently not eligible for the cycle of care initiative fit the criteria of uncomplicated diabetes and are therefore suitable for primary care management. Almost double the proportion of the non-eligible population managed their diabetes without medication. Furthermore, a significantly lower proportion of the non-eligible population were on insulin. In Ireland, attendance at out-patient clinics is free at the point of access, creating a perverse incentive for non-eligible individuals to seek routine diabetes care in secondary care. The roll out of the cycle of care to all people with type 2 diabetes would remove the financial barriers that currently exist to managing uncomplicated diabetes at the right time and in the right place. For integrated care to be implemented, the financing must be aligned with the care pathways.
Using a nationally representative sample, we provide robust estimates of the number of people aged 50 years and over who are currently not eligible for the cycle of care. There are some limitations to be noted. Our estimates only include people aged over 50 years and so the total number of non-eligible people is likely to be higher. Self-reported doctor diagnoses may introduce misclassification bias and result in inaccurate estimates. However, a number of studies have demonstrated that self-report is a suitable method to determine the prevalence of diabetes compared to medical records 17, 18 . The self-reported doctor diagnosis of diabetes may underestimate the true prevalence of diabetes as it does not measure undiagnosed diabetes. However, the prevalence of undiagnosed diabetes has been shown to be low in this cohort 19 . As TILDA does not contain information on diabetes-specific health service use, we were unable to explore attendance rates at outpatient departments compared to GP visits for routine diabetes care.
Our findings highlight the inequity of the cycle of care, particularly for younger people with type 2 diabetes. While a welcome initiative and an important step in the implementation of integrated diabetes care in Ireland, eligibility needs to be based on clinical criteria rather than income. It is essential that the provision of the cycle of care be extended to all people with type 2 diabetes in Ireland.
Data availability
The data presented in this report are part of the TILDA study (Wave 1) 18 . This is available from the Irish Social Studies Archive (ISSDA) through a system of managed open access. You may find it useful to browse the TILDA Register of Use, which lists all projects that have been approved to use TILDA data.
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Diabetes Research Centre, University of Leicester, Leicester, UK In the Introduction, the authors stated that integrated diabetes care has been shown to reduce preventable hospitalisations for diabetes-related complications. In as much as this is true, it will be better to also emphasise that integration of diabetes care within primary care is just as effective Seidu 2016) . The description of the cycle of care here seems like a financial incentive et al. ( intervention, not necessarily an integrated care system. If it is, the authors need to explain how this fits as an integrated care system. The authors defined uncomplicated diabetes as "Patients with uncomplicated type 2 diabetes are defined as patients not on insulin, treated by diet or glucose lowering agents only, controlled HbA1c and no diabetes-related complications". This is a very glucocentric definition, as in recent times, diabetes is now seen to be more than glucose control. For example, a patient with CKD5 and diabetes who has excellent glucose control, even if they are not on insulin, needs to be managed in specialist centres. Therefore, the definition of complex diabetes should take into consideration comorbidities that may otherwise make the management of diabetes complex in the primary care setting, such as heart failure, severe renal failure, morbid obesity, very young type 2 diabetics, etc. Additionally, how do the authors classify patients on GLP1RA? Complex or not complex? These are injectables but not insulin. Does the cycle of care initiative only focus on 2 reviews a year and measurements of processes of care? How about intermediate outcomes such as hbA1c levels and hard outcomes such as hospitalisations for MI, strokes, amputations, blindness and renal failure? Those not eligible for the cycle of care were younger, with only 4.1% aged over 75 years compared to 34.2% of the eligible population. This has serious complications for the population of Ireland. Type 2 diabetes in the young is a very aggressive disease, with patients more likely to suffer all the complications than the elderly. This therefore has the potential of hitting the national economy and the social fabric of Ireland in years to come as this demographic population are productive in the economy and the carers of the young and elderly. This point needs to be made in the discussion to highlight the importance of this finding. The absence of non-statistically significant differences in micro and macro vascular complications between the 2 groups could be because the diagnosis is self-reported. This method can obviously be less reliable. This point needs to be expanded upon in the discussion. If on the other hand, the authors don't think this is a major issue, then they need to explain why the government should 1 
